Semaglutide exposure and elimination were not affected by concomitant cagrilintide administration, supporting further clinical development of the cagrilintide and semaglutide 2.4 mg combination for weight management
Beyond weight reduction alone, these trials have also shown improvements across a range of cardiometabolic markers, including blood pressure, lipid profiles, glycemic control, and inflammatory measures
An initial medical office visit or telemedicine visit is required to begin this therapy
Combinations of GPX4 activator with other anti-inflammation compounds are promising inflammation intervention strategy
If its your first time using GLP-1 care, or if you live in a state that requires live consultations, youll book a brief video appointment with a provider
I'm a pharmacist by trade